T1	Participants 69 85	post-transplant.
T2	Participants 122 412	patients achieving tacrolimus whole-blood concentrations of â‰¥10 ng/mL within 3 days of kidney transplantation, after randomization either to standard dosing (control group) or post-transplantation dosing guided by a 2-hour (C(2) ) level following a preoperative tacrolimus dose (T2 group)
T3	Participants 777 788	monitoring.
T4	Participants 789 857	Participants received concomitant mycophenolate mofetil and steroids
T5	Participants 859 970	RESULTS Ninety patients were recruited, of which 84 were included in the analysis (control group n=43; T2 group
